Search Results

HMN-214 50mg  | ≥99%

CSNpharm

HMN-214 is a potent PLK1 inhibitor an average IC50 of 0.12 μM, and a prodrug of HMN-176, which alters the cellular spatial orientation of Plk1.

More Information Supplier Page

HMN-214 5mg  | ≥99%

CSNpharm

HMN-214 is a potent PLK1 inhibitor an average IC50 of 0.12 μM, and a prodrug of HMN-176, which alters the cellular spatial orientation of Plk1.

More Information Supplier Page

HMN-214 1mg  | ≥99%

CSNpharm

HMN-214 is a potent PLK1 inhibitor an average IC50 of 0.12 μM, and a prodrug of HMN-176, which alters the cellular spatial orientation of Plk1.

More Information Supplier Page

HMN-214 25mg  | ≥99%

CSNpharm

HMN-214 is a potent PLK1 inhibitor an average IC50 of 0.12 μM, and a prodrug of HMN-176, which alters the cellular spatial orientation of Plk1.

More Information Supplier Page

Go6983 5mg  | ≥99%

CSNpharm

Go6983 is a pan-PKC inhibitor against for PKCα, PKCβ, PKCγ and PKCδ with IC50 of 7 nM, 7 nM, 6 nM and 10 nM, respectively and less potent to PKCζ and inactive to PKCμ.

More Information Supplier Page

Go6983 10mg  | ≥99%

CSNpharm

Go6983 is a pan-PKC inhibitor against for PKCα, PKCβ, PKCγ and PKCδ with IC50 of 7 nM, 7 nM, 6 nM and 10 nM, respectively and less potent to PKCζ and inactive to PKCμ.

More Information Supplier Page

SC514 10mg  | ≥99%

CSNpharm

SC514 is a potent, reversible, ATP-competitive and highly selective IKK-β(IKK-2) inhibitor with IC50 value ranging in 3-12 µM.

More Information Supplier Page